Management of hyperglycemia in non-critically ill hospitalized patients: basal-bolus Insulin vs sliding scale Insulin: A Literature Review
(2022). Management of hyperglycemia in non-critically ill hospitalized patients: basal-bolus Insulin vs sliding scale Insulin: A Literature Review. EKB Journal Management System, 2(2), -. doi: 10.21608/esdlj.2022.455800
. "Management of hyperglycemia in non-critically ill hospitalized patients: basal-bolus Insulin vs sliding scale Insulin: A Literature Review". EKB Journal Management System, 2, 2, 2022, -. doi: 10.21608/esdlj.2022.455800
(2022). 'Management of hyperglycemia in non-critically ill hospitalized patients: basal-bolus Insulin vs sliding scale Insulin: A Literature Review', EKB Journal Management System, 2(2), pp. -. doi: 10.21608/esdlj.2022.455800
Management of hyperglycemia in non-critically ill hospitalized patients: basal-bolus Insulin vs sliding scale Insulin: A Literature Review. EKB Journal Management System, 2022; 2(2): -. doi: 10.21608/esdlj.2022.455800

Management of hyperglycemia in non-critically ill hospitalized patients: basal-bolus Insulin vs sliding scale Insulin: A Literature Review

Egyptian Society of Diabetes and Lipidology Journal
Volume 2, Issue 2, October 2022    PDF (661.45 K)
Document Type: Abstracts
DOI: 10.21608/esdlj.2022.455800
Abstract
Hyperglycemia in hospitalized patients is a common and serious finding. Sliding scale insulin is not recommended by many recent guidelines to be used in hospital settings and despite that, it is still the most common strategy in clinical practice in many countries. This review aims to assess the effectiveness and safety of basal-bolus Insulin versus sliding scale Insulin (SSI) in non-critically ill hospitalized patients.
Statistics
Article View: 33
PDF Download: 13